Mechanism of action of didemnin B, a depsipeptide from the sea. 1984

L H Li, and L G Timmins, and T L Wallace, and W C Krueger, and M D Prairie, and W B Im

With the brush border membrane vesicles prepared from the rat kidney cortex, didemnin B and its parent compound, didemnin A function neither as a K+-specific ionophore nor as an ionophore for Na+ ions while other depsipeptide antibiotics such as valinomycin and gramicidin promote transmembrane movement of K+ and Na+ ions, respectively. Didemnin B inhibits protein synthesis and DNA synthesis much more than RNA synthesis and is in general more potent than didemnin A. Time course studies reveal that the action of didemnin B is rapid and cannot be reversed after 2 h in contact with the cells. The inhibition of protein synthesis is almost superimposable to that of L1210 cells growth. DNA synthesis is also markedly inhibited. These results collectively suggest that didemnin B acts differently, at least in part, from other depsipeptide antibiotics and its biological effect is primarily mediated through its inhibition of protein synthesis and to a lesser extent its inhibition of DNA synthesis.

UI MeSH Term Description Entries
D007476 Ionophores Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes. Ionophore
D007672 Kidney Cortex The outer zone of the KIDNEY, beneath the capsule, consisting of KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; and KIDNEY TUBULES, PROXIMAL. Cortex, Kidney
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008297 Male Males
D008871 Microvilli Minute projections of cell membranes which greatly increase the surface area of the cell. Brush Border,Striated Border,Border, Brush,Border, Striated,Borders, Brush,Borders, Striated,Brush Borders,Microvillus,Striated Borders
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

L H Li, and L G Timmins, and T L Wallace, and W C Krueger, and M D Prairie, and W B Im
November 2011, Journal of natural products,
L H Li, and L G Timmins, and T L Wallace, and W C Krueger, and M D Prairie, and W B Im
November 1988, European journal of cancer & clinical oncology,
L H Li, and L G Timmins, and T L Wallace, and W C Krueger, and M D Prairie, and W B Im
June 1988, Proceedings of the National Academy of Sciences of the United States of America,
L H Li, and L G Timmins, and T L Wallace, and W C Krueger, and M D Prairie, and W B Im
October 2023, ACS chemical biology,
L H Li, and L G Timmins, and T L Wallace, and W C Krueger, and M D Prairie, and W B Im
January 1996, International journal of peptide and protein research,
L H Li, and L G Timmins, and T L Wallace, and W C Krueger, and M D Prairie, and W B Im
July 1995, Biochemistry,
L H Li, and L G Timmins, and T L Wallace, and W C Krueger, and M D Prairie, and W B Im
June 2015, Nature chemical biology,
L H Li, and L G Timmins, and T L Wallace, and W C Krueger, and M D Prairie, and W B Im
December 1989, International journal of peptide and protein research,
L H Li, and L G Timmins, and T L Wallace, and W C Krueger, and M D Prairie, and W B Im
December 1991, Cancer,
L H Li, and L G Timmins, and T L Wallace, and W C Krueger, and M D Prairie, and W B Im
October 2007, Mini reviews in medicinal chemistry,
Copied contents to your clipboard!